146 related articles for article (PubMed ID: 10431829)
1. Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells.
Tao M; Miyano-Kurosaki N; Takai K; Takaku H
FEBS Lett; 1999 Jul; 454(3):312-6. PubMed ID: 10431829
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.
Tamura Y; Tao M; Miyano-Kurosaki N; Takai K; Takaku H
Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):87-96. PubMed ID: 10805159
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells.
Abe T; Suzuki S; Hatta T; Takai K; Yokota T; Takaku H
Antivir Chem Chemother; 1998 May; 9(3):253-62. PubMed ID: 9875404
[TBL] [Abstract][Full Text] [Related]
4. The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6.
Ebadi P; Karimi MH; Pourfathollah AA; Saheb Ghadam Lotfi A; Soheili ZS; Samiee S; Hajati S; Nadali F; Geramizadeh B; Moazzeni SM
Iran J Immunol; 2009 Mar; 6(1):1-11. PubMed ID: 19293472
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of hTR activity for suppression of lung cancer cell proliferation using antisense phosphorothioate oligonucleotides].
Mei M; Yu H; Zhang W; Shi J; Yang J
Zhonghua Bing Li Xue Za Zhi; 2000 Jun; 29(3):204-7. PubMed ID: 11866914
[TBL] [Abstract][Full Text] [Related]
7. [Antisense nucleic acid therapy of influenza virus].
Hatta T; Abe T; Takai K; Takaku H
Nihon Rinsho; 1997 Oct; 55(10):2765-71. PubMed ID: 9360404
[TBL] [Abstract][Full Text] [Related]
8. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibitory activity of chimeric oligonucleotides targeting two different sites of human telomerase.
Matthes E; Lehmann C; Stulich M; Wu Y; Dimitrova L; Uhlmann E; Janta-Lipinski MV
Oligonucleotides; 2005 Dec; 15(4):255-68. PubMed ID: 16396620
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
Hatta T; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA in malignant melanoma cells.
Noreen F; Heinrich J; Moelling K
Oligonucleotides; 2009 Jun; 19(2):169-78. PubMed ID: 19441892
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by unmodified, phosphorothioated, and liposomally encapsulated oligonucleotides.
Hatta T; Nakagawa Y; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1996 Jun; 223(2):341-6. PubMed ID: 8670284
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the human chemokine receptor CXCR4 by antisense phosphorothioate oligodeoxyribonucleotides.
Kusunoki A; Saitou T; Miyano-Kurosaki N; Takaku H
FEBS Lett; 2001 Jan; 488(1-2):64-8. PubMed ID: 11163797
[TBL] [Abstract][Full Text] [Related]
14. Antisense phosphorothioate oligonucleotides targeted to the human chemokine receptor CXCR4.
Kusunoki A; Miyano-Kurosaki N; Kimura T; Takai K; Yamamoto N; Gushima H; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1709-19. PubMed ID: 11200267
[TBL] [Abstract][Full Text] [Related]
15. ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.
Jason TL; Figueredo R; Ferguson PJ; Vincent MD; Berg RW; Koropatnick J
DNA Cell Biol; 2008 May; 27(5):229-40. PubMed ID: 18358073
[TBL] [Abstract][Full Text] [Related]
16. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of telomere-mimic phosphorothioate oligodeoxy nucleotides (S-ODNS) on human tumor cell lines.
Saeki T; Takashima S; Tachibana M; Koga M; Hiyama E; Salomon DS; Holland JF; Ohnuma T
Oncology; 1999 Oct; 57 Suppl 2():27-36. PubMed ID: 10545800
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive inhibition of hTERT mRNA expression and telomerase activity by DNA-signal-peptide conjugates.
Kubo T; Bakalova R; Zhelev Z; Ohba H; Fujii M
Nucleic Acids Symp Ser (Oxf); 2005; (49):337-8. PubMed ID: 17150771
[TBL] [Abstract][Full Text] [Related]
19. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
20. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
